Pazopanib cancer drug. 200mg tablet of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-tar

---

Pazopanib cancer drug. 200mg tablet of the anti-cancer drug pazopanib, marketed under the name Votrient. Pazopanib is a potent and selective multi-targeted receptor tyrosine kinase inhibitor that blocks tumour growth and inhibits angiogenesis, the production of new blood vessels. It is used to treat renal cell (kidney) carcinoma and soft tissue sarcoma.

---

Size: 5128px × 3419px
Photo credit: © DR P. MARAZZI/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No

Keywords: -, -life, 1, 200mg, background, blue, cancer, cancers, caplet, caplets, carcinoma, cell, drug, drugs, healthcare, inhibitor, kidney, kinase, life, medical, medicine, multi-targeted, oncological, oncology, pazopanib, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill, pills, prescribed, prescription, receptor, renal, sarcoma, selective, single, soft, tissue, tyrosine, votrient